Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 44,500 shares, a growth of 178.1% from the September 30th total of 16,000 shares. Based on an average daily volume of 71,093 shares, the short-interest ratio is currently 0.6 days.
Voyageur Pharmaceuticals Stock Performance
VYYRF stock opened at $0.02 on Friday. Voyageur Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $1.03. The firm’s 50-day moving average price is $0.11 and its two-hundred day moving average price is $0.10.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd. is a Canadian pharmaceutical company focused on developing, manufacturing and commercializing contrast media used in medical imaging. Its products are designed to help healthcare professionals visualize internal organs and structures during diagnostic procedures.
The company’s primary focus is on barium sulfate and iodinated contrast media. Barium sulfate products are used in gastrointestinal imaging, while iodinated agents are used in procedures such as computed tomography and other X-ray-based examinations.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
